INC focuses on study startup; Factory-CRO touts 'clinical trial rescue';

> The Netherlands' Factory-CRO has launched a clinical trial rescue offering, promising to step in and help medical device sponsors detect problems in study designs before they derail programs. Item

> INC Research is homing in on early-stage research, appointing Carol Aliyar to serve as senior vice president of study startup and tasking her with fostering relationships with trial sites to improve timelines. More

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.